Colleen McGregor

Appearances

EPIGENOME-WIDE PERIPHERAL BLOOD DNA METHYLATION PROFILES ACCURATELY PREDICT ENDOSCOPIC- AND CLINICAL RESPONSE AND REMAIN HIGHLY STABLE DURING INDUCTION AND MAINTENANCE TREATMENT WITH ADALIMUMAB, VEDOLIZUMAB AND USTEKINUMAB IN CROHN’S DISEASE PATIENTS
Date
May 7, 2023
The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Presenter
Vincent Joustra
Speakers
Andrew Li Yim
Ishtu Hageman
Evgeni Levin
Alexandra Noble
Thomas Chapman
Colleen McGregor
Alex Adams
Jack Satsangi
Wouter J. De Jonge
AMC
Peter Henneman
Geert D’Haens
Deciphering the Innate Immune Landscape and Host-Microbial Interactions in IBD
Date
May 18, 2024
MACROPHAGE LRRK2 HYPERACTIVITY IMPAIRS AUTOPHAGY AND INDUCES PANETH CELL DYSFUNCTION AND INTESTINAL INFLAMMATION
Moderators
Shrinivas Bishu
University of Michigan
Beth McCormick
University of Massachusetts Medical School
Speakers
Ta-Chiang Liu
Silvia Pires
Hajar Hazime
Tatsuya Dokoshi
Wanyi Zeng
Colleen McGregor